Home Page |
References | OMIM | Gene | GeneReviews | HGMD | HGNC |
GENATLAS PHENOTYPE |
last update : 19-04-2011 |
Symbol | PWS |
Location | 15q11.2-q13 |
Name | Prader-Willi syndrome |
Corresponding gene | SNRPN , SNORD116@ , NDN , MAGEL2 , OCA2 |
Other symbol(s) | DEL15Q12, UPD15M |
Main clinical features |
|
Genetic determination | chromosomal |
genomic disorder | |
epigenetic | |
Prevalence | ~1/22,000 livebirths but with a population prevalence of ~1/54,000 |
Function/system disorder | multisystem/generalized |
mental retardation | |
Type | MCA/MR |
Gene product |
Name | contiguous gene syndrome, including five paternally expressed genes that encode polypeptides : SNURF-SNRPN, MKRN3, MAGEL2, and NDN. SNRPN is a small ribonuclear protein involved in alternative mRNA splicing. No abnormal gene product associated with PWS has been identified |
Mechanism(s) |
Gene mutation | Chromosome rearrangement | Effect | Comments |
|  
| deletion
| haploinsufficiency
| genomic disorder, typically deleted region between BP1-BP3 (class I), or between BP2-BP3 (class II) on the paternal chromosome
|  
| uniparental disomy
| absent protein
| maternal UPD, associated with advanced maternal age (trisomy rescue)
| imprinting defect
|  
| absent protein
| microdeletions or LOI at the 3'end of the ICR
| |
Remark(s) |
|
Genotype/Phenotype correlations |
|